Previous Close | 0.8500 |
Open | 0.8500 |
Bid | 0.8500 x N/A |
Ask | 1.1500 x N/A |
Day's Range | 0.8500 - 0.8500 |
52 Week Range | 0.8500 - 0.8500 |
Volume | |
Avg. Volume | 0 |
Market Cap | 4.517M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 21.25 |
EPS (TTM) | 0.0400 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TORONTO, March 28, 2023--In connection with its Reverse Takeover Transaction (the "Proposed Transaction") with Phoenix Canada Oil Company Limited (TSXV: PCO) ("Phoenix"), as originally announced on May 30, 2022, ZYUS Life Sciences Inc. ("ZYUS" or the "Company") is pleased to announce its intention to complete a concurrent brokered private placement offering of subscription receipts for gross proceeds of C$20,000,000 or such greater amount as agreed to between the Company and the Agents, which sh
TORONTO, March 13, 2023 (GLOBE NEWSWIRE) -- Phoenix Canada Oil Company Limited (TSX-V: PCO) (“Phoenix”) and ZYUS Life Sciences Inc. (“ZYUS”), a private Canadian life sciences company, together announce that they have received conditional approval from the TSX Venture Exchange (“Exchange”) to pursue a reverse takeover transaction in accordance with the terms outlined in the Definitive Agreement (“Agreement”) dated November 16, 2022 and as amended on March 10, 2023. The Agreement outlined the term
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix") and ZYUS Life Sciences Inc. ("ZYUS" or the "Company"), a private Canadian life sciences company, together announce that they have entered into a Definitive Agreement dated November 15, 2022 (the "Agreement"). The Agreement is the Definitive Agreement contemplated by the non-binding letter of intent Phoenix and ZYUS entered into on May 27, 2022 and announced by press release dated May 30, 2022.
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix" or the "Company") is pleased to provide an update to the Company's previously announced non-binding letter of intent (the "LOI") dated May 27, 2022 with ZYUS Life Sciences Inc. ("ZYUS"), a private Canadian life sciences company.